Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07673016 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

Study acronym: INSITE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a prospective, multicenter observational study designed to collect urine and tumor biospecimens and associated clinical data from patients undergoing evaluation, treatment, or surveillance for urothelial carcinoma.
Trial Details
NCT Number NCT07673016
Lead Sponsor Convergent Genomics, Inc.
Conditions
(from sponsor)		 Bladder Cancer, Urothelial Carcinoma (UC), Hematuria, Upper Tract Urothelial Cancer
Related terms Carcinoma, Transitional Cell, Hematuria, Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms
Enrollment 2,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov